is retatrutide glp 1 Triple Agonist (GLP-1/GIP/GCG) Diagram showing the mechanism of
Description
A new class of glucose-lowering therapy for type 2 diabetes: the latest development in the incretin arena

ZepBound, launched for obesity in late 2023, quickly added hundreds of millions in sales by mid-2025, its global sales were already in the hundreds of millions as clinics rolled out the new weight-loss injection

Benefits of GLP-1 Treatment Patients choose GLP-1 medical weight loss for its broad range of health and aesthetic benefits, including: Significant fat loss without extreme dieting or strenuous exercise Decreased BMI and improved body composition Targeting of stubborn abdominal fat Nonsurgical, minimally invasive treatment Improved cholesterol, blood pressure, and blood sugar levels Enhanced metabolic function and energy balance Am I a Good Candidate for GLP-1s

Hot flushes: What causes them and how to manage them Menopause and breast cancer: How to cope Questions to ask your care team If you have concerns about foods, supplements or medications while taking tamoxifen, these questions may help: Are any of my current medications or supplements known to interact with tamoxifen

It is important to note that whilst GLP-1 receptor agonists are not specifically licensed for "menopausal weight gain" as a distinct indication, they may be prescribed for women meeting criteria for obesity treatment or type 2 diabetes management during the menopausal transition
The RAND Education and Labor division is dedicated to improving education and expanding economic opportunities for all through research and analysis